USpharma Ltd., a pharmaceutical development and manufacturing company commercializing several novel delivery platforms, today announced a significant growth equity investment by 1315 Capital, a Philadelphia-based healthcare growth equity firm.
Press Release
SciSafe, a leading provider of biological and pharmaceutical storage services, today announced its acquisition and growth capital investment by 1315 Capital, a Philadelphia-based growth equity firm specializing in healthcare. The acquisition from BioLife Solutions and establishment of SciSafe as a standalone business enables the company to focus on the expansion of its customized and comprehensive biostorage solutions.
Experic, a US-based contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the global biopharmaceutical industry, today announced a significant growth capital investment led by 1315 Capital, a Philadelphia-based, growth equity firm focused on healthcare, with participation from its existing investors including East Seattle Partners, Harro Höfliger Packaging Systems, Inc. and Kineticos …
Primrose Bio, Inc. (“Primrose,” the “Company”), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in therapeutics and vaccines, announced a significant equity investment from 1315 Capital, a Philadelphia-based, healthcare-focused growth equity firm.